| Literature DB >> 16606366 |
Katsutoshi Furukawa1, Michiko Matsuzaki-Kobayashi, Takafumi Hasegawa, Akio Kikuchi, Naoto Sugeno, Yasuto Itoyama, Yue Wang, Pamela J Yao, Ittai Bushlin, Atsushi Takeda.
Abstract
Mutations in alpha-synuclein cause some cases of familial Parkinson's disease (PD), but the mechanism by which alpha-synuclein promotes degeneration of dopamine-producing neurons is unknown. We report that human neural cells expressing mutant alpha-synuclein (A30P and A53T) have higher plasma membrane ion permeability. The higher ion permeability caused by mutant alpha-synuclein would be because of relatively large pores through which most cations can pass non-selectively. Both the basal level of [Ca2+]i and the Ca2+ response to membrane depolarization are greater in cells expressing mutant alpha-synuclein. The membrane permeable Ca2+ chelator BAPTA-AM significantly protected the cells against oxidative stress, whereas neither L-type (nifedipine) nor N-type (omega-conotoxin-GVIA) Ca2+ channel blockers protected the cells. These findings suggest that the high membrane ion permeability caused by mutant alpha-synuclein may contribute to the degeneration of neurons in PD.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16606366 DOI: 10.1111/j.1471-4159.2006.03803.x
Source DB: PubMed Journal: J Neurochem ISSN: 0022-3042 Impact factor: 5.372